States mandating hpv
Photo by Joe Raedle / Getty Images file Nine years after the HPV vaccine was first approved in the U. C., currently require the vaccine for school entry, according to new research.
Vaccination rates have remained mostly static for the vaccines that protect young people against infection by certain strains of the human papillomavirus (HPV), the most common sexually transmitted infection (STI) in the United States.
The vaccines were originally recommended only for girls and young women and were subsequently broadened to include boys and young men. is widespread; there are more than 14 million new infections annually, and it is estimated that 50% of sexually active men and women will get HPV at some point in their lives. Preventive Services Task Force recommend that most women ages 21 to 65 receive a Pap test once every three years.
This factsheet discusses HPV and related cancers, use of the HPV vaccines for both females and males, and insurance coverage and access to the vaccines. Cervical cancer is usually treatable, especially when detected early through routine screening with Pap tests. In recent years, some professional associations and committees have recommended screening certain populations of women with a test for high-risk HPV DNA, but this recommendation continues to be debated.
HPV vaccines are unique in their ability to prevent cancer. There are, however, still a number of financing, public acceptance, and delivery system challenges that must be addressed to enable widespread uptake of this important advance in cancer prevention.
Jason Schwartz, an ethics researcher at Princeton University who led a study published Tuesday in the Journal of the American Medical Association examining the state requirements. Healthy People 2020, a 10-year set of health goals run by the U. Department of Health and Human Services, recommends 80 percent of adolescents receive the HPV vaccine by 2020.
Clearly, we’re falling well short of that goal, Schwartz said. Denise Galloway, a virologist at Fred Hutchinson Cancer Research Center who made critical discoveries that definitively linked the virus to cervical and other cancers, believes that resistance is because of how the virus is transmitted.